Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 628 of 5804
-
New chemo combo tested to extend life in Hard-to-Treat stomach and esophageal cancers
Disease control Recruiting nowThis phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esopha…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New blood test aims to slash unnecessary antibiotics in ER lung infections
Disease control Recruiting nowThis is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibioti…
Phase: NA • Sponsor: MeMed Diagnostics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Frozen poop pills could tame ulcerative colitis
Disease control Recruiting nowFRESCO is a randomized, longitudinal, prospective, three arm, multicentre, double blind study to determine safety and efficacy of repeated faecal microbiota transplantation (FMT) or faecal microbiota filtrate transplantation (FMFT) compared to placebo using oral, frozen capsules …
Phase: PHASE3 • Sponsor: Andreas Stallmach • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Engineered cells take on tough blood cancer in first human trial
Disease control Recruiting nowFirst in humans, exploratory, open-label, single-arm, multicentre, non-competitive, dose escalation study to assess the safety and efficacy of CD1a-CAR T therapy in patients with relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LL)
Phase: PHASE1 • Sponsor: OneChain Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug combo aims to wipe out CLL cells, guided by a simple blood test
Disease control OngoingThis phase II trial studies how well pirtobrutinib and venetoclax work in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. This study also seeks to adopt a blood test which shows a small number of cancer cells in the body after cancer treatment c…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Timing of brain radiation could change outcomes for cancer patients
Disease control Recruiting nowThis is a phase III randomized trial with the aim to compare preoperative HSRS to postoperative HSRS in patients with large at least one BMs from solid tumors suitable for surgical resection.
Phase: NA • Sponsor: Istituto Clinico Humanitas • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug ecopipam shows promise for Tourette's tics in Late-Stage trial
Disease control CompletedThis Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by a double-blind, placebo-controll…
Phase: PHASE3 • Sponsor: Emalex Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Sound waves take on tough pancreatic cancer
Disease control OngoingThe purpose of this study is to evaluate the safety and efficacy of standard chemotherapy with or without a novel High Intensity Focused Ultrasound system (Code: Suizenji) in patients with unresectable pancreatic cancer who are refractory or intolerant to first-line chemotherapy.
Phase: NA • Sponsor: SONIRE Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could less radiation be enough? new trial aims to reduce side effects for throat cancer patients
Disease control OngoingThis is a single-arm, phase II study to establish the safety of reducing radiation dose in selected HPV-Associated OPSCC patients receiving adjuvant radiation after TORS and neck dissection. This protocol also allows for sparing of the primary resection bed, in appropriate patien…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New pill could ease severe asthma attacks
Disease control OngoingThe purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life. In addition, the study will further evaluate the safe…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC
-
New shot could tame teen eczema
Disease control CompletedThe primary objective of this study is to describe the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe AD.
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
AI app aims to catch deadly skin cancer early in rare disease patients
Diagnosis OngoingIn this study, an artificial intelligence model to detect squamous cell carcinomas (SCC) on photos of recessive dystrophic epidermolysis bullosa (RDEB) skin is developed. The ultimate goal is to integrate this model into an app for patients and physicians, to help detect SCCs in …
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Could a common thyroid pill slow brain tumor growth?
Disease control Recruiting nowThe purpose of this study is to test the effectiveness, safety, and tolerability of a drug called Methimazole. The investigational drug, Methimazole is not FDA approved for brain tumors, but it is used to treat thyroid illnesses. Different doses of Methimazole will be given to se…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Nose spray could block COVID spread in homes
Prevention CompletedCoronavirus-induced disease 2019 (COVID-19) is an infection caused by a virus whose full name is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is a new and rapidly-spreading infectious disease which carries a significant risk of death, has brought massive eco…
Phase: PHASE2, PHASE3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Blood test may revolutionize cancer treatment selection
Knowledge-focused Recruiting nowOverall, this project has three main goals: first, to ascertain the feasibility of the approach and identify whether liquid biopsies can detect actionable mutations that can be utilized to generate precision oncology treatment recommendations. Second, the investigators will inves…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo aims to boost lymphoma treatment
Disease control OngoingThis phase I/II trial tests the safety of tafasitamab, retifanlimab, and rituximab (TRR) as a prephase treatment and in combination with standard therapy consisting off cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or polatuzumab vedotin, cyclophosphamide, dox…
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New program aims to cut teen suicide events in half
Disease control Recruiting nowThis protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, s…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New combo aims to shrink lymphoma tumors with less chemo
Disease control OngoingThis study is planned as a single arm clinical trial of tazemetostat in combination with bendamustine and rituximab with both a phase I and phase II component. All patients will receive tazemetostat twice daily on days 1-28 in combination with bendamustine 90 mg/m2 IV on days 1 a…
Phase: PHASE1, PHASE2 • Sponsor: Vaishalee Kenkre • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Deeper stroke Check-Ups could slash repeat risk
Disease control ENROLLING_BY_INVITATIONAnnually, about 4000 Swedes suffer a recurrent stroke, and for many, their lives change dramatically. To prevent recurring strokes, knowledge about the individual's risk of recurrence is needed to tailor an effective preventive medical treatment. The purpose of the SALSA study i…
Phase: NA • Sponsor: Region Stockholm • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart pouch closure during surgery may slash stroke risk
Prevention OngoingThis trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects …
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC